HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c) [Phase 4]
Phase 4 trial evaluating reversibility of CNS-related neurotoxicity after switching to a darunavir/cobicistat-based regimen in people with H…
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Switch to TAF+FTC+BIC in HIV-1-infected Patients Over 65 Years Old at Risk of Polymedication [Phase 4]
Phase 4 clinical trial examining switching to TAF+FTC+BIC in HIV-1-infected patients over 65 at risk of polypharmacy.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI Resistance [Phase 3]
Phase 3 trial evaluating DORavirine in adults with HIV experiencing virological failure on first-line efavirenz-based ART with NNRTI resista…
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals [Phase 2]
Phase 2 trial update evaluating doravirine concentrations and antiviral activity in genital fluids from HIV-1 infected individuals.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients [Phase 2]
A Phase 2 clinical trial update evaluating UB-421 for functional cure potential in ART-stabilized HIV-1 patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients [Phase 2]
Phase 2 trial update assessing the HIV functional cure potential of UB-421 in ART-stabilized HIV-1 patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: The BRIgHT Program: Building Resilience in HIV Together [NA]
A completed clinical trial (BRIgHT Program) evaluating resilience in HIV-related psychological conditions; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Open Label Extension (OLE) of the TDF2 Study, Botswana [NA]
Open-label extension update for the TDF2 study conducted in Botswana, completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants [Phase 1]
This Phase 1 trial update evaluates the safety and immunogenicity of an HIV-1 gp41 MPER-656 liposome vaccine in healthy, HIV-uninfected adul…
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals [Phase 3]
A Phase 3 trial update reports on doravirine concentrations and antiviral activity in cerebrospinal fluid of HIV-1 infected individuals.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up [Phase 2, Phase 3]
Phase 2/Phase 3 trial update comparing treatments for HIV-infected opioid users within an integrated care model (CHOICES) completed with res…
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011) [Phase 2]
Phase 2 trial update for islatravir with doravirine and lamivudine in HIV-1 infection completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Resistance Testing to Improve Management of Virologic Failure in Sub-Saharan Africa [NA]
A completed clinical trial evaluating resistance testing to improve management of virologic failure in HIV/AIDS patients in Sub-Saharan Afri…
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: HIV Non-Occupational Post-Exposure Prophylaxis [Phase 4]
Phase 4 clinical trial update on non-occupational post-exposure prophylaxis for HIV has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial [Phase 3]
Phase 3 trial evaluating high-dose vitamin D3 supplementation in HIV-1 infection patients with vitamin D deficiency has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection [Phase 3]
Phase 3 trial assessing safety and efficacy of triptolide wilfordii in new onset HIV-1 infection has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Biktarvy for Non-Occupational Post-Exposure Prophylaxis (nPEP) [Phase 4]
Phase 4 trial update for Biktarvy used as non-occupational post-exposure prophylaxis (nPEP) in HIV prevention; study completed.
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants [Phase 3]
Phase 3 clinical trial evaluating DTaP-IPV-HB-PRP-T as a primary series and a second-year booster in HIV-exposed infants (infected and uninf…
-
CLINICAL_TRIALS trial_result · 2022-04-01Clinical Trial Update: EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONS [Phase 4]
Phase 4 trial evaluating a simplification strategy using dolutegravir and darunavir/cobicistat versus optimized treatment in suppressed HIV-…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Adolescent Transition To Adult Care for HIV-infected Adolescents in Kenya [NA]
Clinical trial update on transitioning HIV-infected adolescents in Kenya to adult care; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use [NA]
A completed clinical trial studying how timing of ART initiation and alcohol use affect outcomes in early HIV infection.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents [Phase 1, Phase 2]
This clinical trial update reports safety and immune response data for dolutegravir in HIV-1 infected infants, children, and adolescents fro…
-
CLINICAL_TRIALS trial_result · 2022-03-07Clinical Trial Update: Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants [Phase 1]
Phase 1 study evaluating safety and pharmacokinetics of the HIV broadly neutralizing antibody VRC07-523LS in healthy, HIV-uninfected adults;…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Sustainable East Africa Research in Community Health [NA]
Clinical trial update from a UCSF-sponsored study completed in 2022, focusing on HIV and tuberculosis with additional conditions listed in t…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: The Development of a Mobile-based App to Increase Uptake of Pre-Exposure Prophylaxis (PrEP) by Men Who Have Sex With Men in China [NA]
Clinical trial update on a mobile app designed to increase PrEP uptake among men who have sex with men in China; completed with results post…